Tada Katsuhiko, Miyagi Yasunari, Yasuhi Ichiro, Tsumura Keisuke, Emoto Ikuko, Sagawa Maiko, Tanaka Norifumi, Yamaguchi Kyohei, Maeda Kazuhisa, Kawakami Kosuke
Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, 1711-1 Tamasu, Kita Ward, Okayama 701-1192, Japan.
Medical Data Labo, 289-48 Yamasaki, Naka Ward, Okayama 703-8267, Japan.
J Clin Med. 2025 Jul 22;14(15):5179. doi: 10.3390/jcm14155179.
We define severe postpartum hemorrhage (PPH) with macroscopic hematuria as clinical disseminated intravascular coagulation (DIC), a life-threatening condition. We also report a methodology using machine learning, a subtype of artificial intelligence, for developing the boundary criterion for predicting hematuria on the fibrinogen-fibrin/fibrinogen degradation product (FDP) plane. A positive FDP-fibrinogen/3-60 (mg/dL) value indicates hematuria; otherwise, non-hematuria is observed. We aimed to validate this criterion using severe placental abruption (PA), and to examine the activation of the coagulation-fibrinolytic system in clinical DIC. Of 17,285 deliveries across nine perinatal centers in Japan between 2020 and 2024, 13 had severe PA without hematuria, 18 had severe PPH without hematuria, and 3 had severe PPH with hematuria, i.e., clinical DIC. We calculated the values of the criterion formula for 13 cases of severe PA to validate the boundary criterion and compared the laboratory tests for coagulation-fibrinolytic activation among the three groups. The calculated values using the criterion for the 13 PA without hematuria ranged from -108.91 to -5.87 and all were negative. In cases of clinical DIC, fibrinogen levels (median, 62 mg/dL) were lower ( < 0.05), while levels of FDP (96 mg/dL), the thrombin-antithrombin complex (120 ng/mL), and the plasmin-α-plasmin inhibitor complex (28.4 μg/mL) were significantly higher than in the other two groups. This study demonstrated the validity of the boundary criterion for predicting hematuria using severe PA. The coagulation-fibrinolytic test results suggested that PPH cases with hematuria were assumed to have clinical DIC, indicating that this criterion may be considered for diagnosing DIC during delivery. However, further additional patient data are needed to confirm the usefulness of this criterion because of the very low number of hematuria cases.
我们将伴有肉眼血尿的严重产后出血(PPH)定义为临床弥散性血管内凝血(DIC),这是一种危及生命的状况。我们还报告了一种使用机器学习(人工智能的一个子类型)的方法,用于在纤维蛋白原 - 纤维蛋白/纤维蛋白原降解产物(FDP)平面上制定预测血尿的边界标准。FDP - 纤维蛋白原/3 - 60(mg/dL)值为阳性表明存在血尿;否则,观察到的为非血尿。我们旨在使用严重胎盘早剥(PA)来验证该标准,并研究临床DIC中凝血 - 纤维蛋白溶解系统的激活情况。在2020年至2024年期间,日本九个围产期中心的17285例分娩中,13例有严重PA但无血尿,18例有严重PPH但无血尿,3例有严重PPH伴血尿,即临床DIC。我们计算了13例严重PA病例的标准公式值以验证边界标准,并比较了三组之间凝血 - 纤维蛋白溶解激活的实验室检查结果。13例无血尿的PA病例使用该标准计算出的值范围为 - 108.91至 - 5.87,均为阴性。在临床DIC病例中,纤维蛋白原水平(中位数,62 mg/dL)较低(<0.05),而FDP水平(96 mg/dL)、凝血酶 - 抗凝血酶复合物(120 ng/mL)和纤溶酶 - α - 纤溶酶抑制剂复合物(28.4 μg/mL)明显高于其他两组。本研究证明了使用严重PA预测血尿的边界标准的有效性。凝血 - 纤维蛋白溶解试验结果表明,伴有血尿的PPH病例被认为患有临床DIC,这表明该标准可用于分娩期间DIC的诊断。然而,由于血尿病例数量极少,需要更多的患者数据来证实该标准的实用性。